A Validated HPTLC Densitometric Method for The Quantitative Determination of Ubidecarenone in Bulk and in Capsule Formulation

A. Karunakaran, Anjana Elampulakkadu, Ramesh Jayaprakash, S. Raju, Meka Dharshini Lakshmiganesh
{"title":"A Validated HPTLC Densitometric Method for The Quantitative Determination of Ubidecarenone in Bulk and in Capsule Formulation","authors":"A. Karunakaran, Anjana Elampulakkadu, Ramesh Jayaprakash, S. Raju, Meka Dharshini Lakshmiganesh","doi":"10.24123/mpi.v3i4.4734","DOIUrl":null,"url":null,"abstract":"A new, simple, precise, accurate and rapid high performance thin layer chromatographic method has been developed and validated for the estimation of ubidecarenone in bulk and in capsule formulation. The chromatographic separation was performed on aluminium TLC plates precoated with silica gel 60F254 as a stationary phase and methanol:water (7:3) as a mobile phase. Detection was performed densitometrically in the absorbance mode at 280nm for the evaluation of chromatograms. The system has given well sharp peak of ubidecarenone (Rf=0.51±0.02). The linearity of the method was established in the range of 1-6 ng/µL with correlation coefficient (r2) of 0.9995. The method was validated for precision, accuracy, robustness, ruggedness, LOD, and LOQ as per ICH guidelines. The limit of detection was found to be 0.0392 ng/µL, whereas the limit of quantitation was found to be 0.1189 ng/µL. The percentage label claim for ubidecarenone in the capsule formulation was found to be 99.96±0.4703. The accuracy of the method was confirmed by recovery studies. The percentage recovery was found to be in the range of 100.10-101.45% for ubidecarenone. The % RSD value was found to be less than 2. The low %RSD value indicates that there is no interference due to excipients used in the formulation. Hence, the developed method was found to be simple, precise, accurate, and rapid for the analysis of ubidecarenone in bulk and pharmaceutical formulation and it can be effectively applied for the quality control analysis of ubidecarenone in bulk and pharmaceutical formulation.","PeriodicalId":18807,"journal":{"name":"MPI (Media Pharmaceutica Indonesiana)","volume":"53 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MPI (Media Pharmaceutica Indonesiana)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24123/mpi.v3i4.4734","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A new, simple, precise, accurate and rapid high performance thin layer chromatographic method has been developed and validated for the estimation of ubidecarenone in bulk and in capsule formulation. The chromatographic separation was performed on aluminium TLC plates precoated with silica gel 60F254 as a stationary phase and methanol:water (7:3) as a mobile phase. Detection was performed densitometrically in the absorbance mode at 280nm for the evaluation of chromatograms. The system has given well sharp peak of ubidecarenone (Rf=0.51±0.02). The linearity of the method was established in the range of 1-6 ng/µL with correlation coefficient (r2) of 0.9995. The method was validated for precision, accuracy, robustness, ruggedness, LOD, and LOQ as per ICH guidelines. The limit of detection was found to be 0.0392 ng/µL, whereas the limit of quantitation was found to be 0.1189 ng/µL. The percentage label claim for ubidecarenone in the capsule formulation was found to be 99.96±0.4703. The accuracy of the method was confirmed by recovery studies. The percentage recovery was found to be in the range of 100.10-101.45% for ubidecarenone. The % RSD value was found to be less than 2. The low %RSD value indicates that there is no interference due to excipients used in the formulation. Hence, the developed method was found to be simple, precise, accurate, and rapid for the analysis of ubidecarenone in bulk and pharmaceutical formulation and it can be effectively applied for the quality control analysis of ubidecarenone in bulk and pharmaceutical formulation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高效液相色谱密度法定量测定乌比迪卡酮原料药和胶囊制剂的含量
建立了一种简便、精确、准确、快速的高效薄层色谱法,用于乌比迪卡酮原料药和胶囊制剂的含量测定。以硅胶60F254为固定相,甲醇:水(7:3)为流动相,预先包被的铝质薄层色谱板进行色谱分离。在280nm吸光度模式下进行密度检测,以评价色谱图。该体系具有良好的乌比卡酮峰峰(Rf=0.51±0.02)。方法在1 ~ 6 ng/µL范围内线性良好,相关系数(r2)为0.9995。根据ICH指南验证了该方法的精密度、准确度、稳健性、坚固性、LOD和LOQ。检测限为0.0392 ng/µL,定量限为0.1189 ng/µL。乌比卡酮在胶囊制剂中的标签声称含量百分比为99.96±0.4703。回收率研究证实了该方法的准确性。乌比卡酮的回收率在100.10 ~ 101.45%之间。发现% RSD值小于2。低%RSD值表明制剂中使用的辅料没有干扰。本方法简便、精密度高、准确度高、快速,可用于乌比德卡酮原料药和制剂的质量控制分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Pengaruh Telefarmasi Terhadap Kepatuhan dan Target Pengobatan Pasien DMT2 RP-HPLC Method Validation for Purity Assay of α-Mangostin Isolate Efektivitas Tonikum Tepung Ikan Sepat Rawa (Trichopodus thricopterus) Dengan Metode Rotarod Test Pengaruh Obat Antituberkulosis Kombinasi RHZE Terhadap Peningkatan Kadar Asam Urat Hubungan Pelayanan Farmasi dengan Kepatuhan Pengobatan Pasien Penyakit Paru Obstruktif Kronik (PPOK)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1